CD8A and neoplasm: Several assays have been developed to study the TIME—perhaps the most notable among them being the Immunoscore assay which assesses T-cell cytotoxicity (CD3/CD8 density) both within and around the tumor as both a metastasis predictor and independent recurrence risk factor.7